ZINC ACETATE DIHYDRATE

( DrugBank: Zinc, Zinc acetate, Acetate / KEGG DRUG: Zinc acetate )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
171	ウィルソン病	13

171. ウィルソン病

臨床試験数 : 79 / 薬物数 : 77 - (DrugBank : 17) / 標的遺伝子数 : 6 - 標的パスウェイ数 : 30

trials per page:

Showing 1 to 10 of 13 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2017-004135-36-NL (EUCTR)	30/03/2020	16/10/2019	Study to Evaluate the Efficacy and Safety of ALXN1840 in pPtients with Wilson Disease.	A Phase 3, Randomized, Rater-Blinded, Multi-Center Study To Evaluate The Efficacy And Safety Of ALXN ...	Wilson Disease MedDRA version: 20.0;Level: LLT;Classification code 10047988;Term: Wilson's disease;S ...	Product Name: ALXN1840 INN or Proposed INN: Not applied Other descriptive name: BIS-CHOLINE TETRATHIOM ...	Alexion Pharmaceuticals, Inc	NULL	Not Recruiting			Female: yes Male: yes	180	Phase 3	United States;Portugal;Serbia;Taiwan;Hong Kong;Greece;Spain;Israel;Russian Federation;Colombia;Italy ...
2	EUCTR2017-004135-36-PT (EUCTR)	13/01/2020	26/03/2019	A Phase 3 clinical study to Evaluate the Efficacy and Safety of ALXN1840 in adult and adolescent pat ...	A Phase 3, Randomized, Rater-Blinded, Multi-Center Study To Evaluate The Efficacy And Safety Of ALXN ...	Wilson Disease MedDRA version: 20.0;Level: LLT;Classification code 10047988;Term: Wilson's disease;S ...	Product Name: ALXN1840 INN or Proposed INN: Not applied Other descriptive name: BIS-CHOLINE TETRATHIOM ...	Alexion Pharmaceuticals, Inc	NULL	Not Recruiting			Female: yes Male: yes	180	Phase 3	United States;Portugal;Serbia;Hong Kong;Taiwan;Spain;Israel;Russian Federation;Colombia;France;Denma ...
3	EUCTR2017-004135-36-SE (EUCTR)	29/10/2019	16/04/2019	A Phase 3 clinical study to Evaluate the Efficacy and Safety of ALXN1840 in adult and adolescent pat ...	A Phase 3, Randomized, Rater-Blinded, Multi-Center Study To Evaluate The Efficacy And Safety Of ALXN ...	Wilson Disease MedDRA version: 20.0;Level: LLT;Classification code 10047988;Term: Wilson's disease;S ...	Product Name: ALXN1840 INN or Proposed INN: Not applied Other descriptive name: BIS-CHOLINE TETRATHIOM ...	Alexion Pharmaceuticals, Inc	NULL	Not Recruiting			Female: yes Male: yes	180	Phase 3	Serbia;United States;Portugal;Taiwan;Hong Kong;Spain;Russian Federation;Israel;Colombia;France;Austr ...
4	EUCTR2017-004135-36-DK (EUCTR)	16/10/2019	05/08/2019	A Phase 3 clinical study to Evaluate the Efficacy and Safety of ALXN1840 in adult and adolescent pat ...	A Phase 3, Randomized, Rater-Blinded, Multi-Center Study To Evaluate The Efficacy And Safety Of ALXN ...	Wilson Disease MedDRA version: 20.0;Level: LLT;Classification code 10047988;Term: Wilson's disease;S ...	Product Name: ALXN1840 INN or Proposed INN: tiomolibdic acid Other descriptive name: BIS-CHOLINE TETRA ...	Alexion Pharmaceuticals, Inc	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	180	Phase 3	Serbia;United States;Portugal;Taiwan;Hong Kong;Spain;Israel;Russian Federation;Colombia;France;Austr ...
5	EUCTR2017-004135-36-FR (EUCTR)	14/09/2018	15/01/2018	A Phase 3 clinical study to Evaluate the Efficacy and Safety of WTX101 in adult patients who suffer ...	A Phase 3, Randomised, Rater-Blinded, Multi-Centre Study to Evaluate the Efficacy and Safety of WTX1 ...	Wilson Disease;Therapeutic area: Body processes [G] - Metabolic Phenomena [G03]	Product Name: WTX101 Product Code: WTX101 INN or Proposed INN: Not applied Other descriptive name: BIS- ...	Wilson Therapeutics AB	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	102	Phase 3	United States;Portugal;Spain;Austria;Israel;United Kingdom;Italy;France;Czech Republic;Hungary;Belgi ...
6	EUCTR2017-004135-36-ES (EUCTR)	27/04/2018	22/01/2018	A Phase 3 clinical study to Evaluate the Efficacy and Safety of WTX101 in adult patients who suffer ...	A Phase 3, Randomised, Rater-Blinded, Multi-Centre Study to Evaluate the Efficacy and Safety of WTX1 ...	Wilson Disease;Therapeutic area: Body processes [G] - Metabolic Phenomena [G03]	Product Name: WTX101 Product Code: WTX101 INN or Proposed INN: Not applied Other descriptive name: BIS- ...	Wilson Therapeutics AB	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	102	Phase 3	France;United States;Hungary;Czech Republic;Poland;Spain;Austria;Israel;Germany;Italy;United Kingdom ...
7	EUCTR2017-004135-36-GB (EUCTR)	23/03/2018	19/12/2017	A Phase 3 clinical study to Evaluate the Efficacy and Safety of WTX101 in adult patients who suffer ...	A Phase 3, Randomised, Rater-Blinded, Multi-Centre Study to Evaluate the Efficacy and Safety of WTX1 ...	Wilson Disease;Therapeutic area: Body processes [G] - Metabolic Phenomena [G03]	Product Name: WTX101 Product Code: WTX101 INN or Proposed INN: Not applied Other descriptive name: BIS- ...	Wilson Therapeutics AB	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	102	Phase 3	United States;Portugal;Spain;Austria;Israel;United Kingdom;Italy;France;Czech Republic;Hungary;Belgi ...
8	EUCTR2017-004135-36-DE (EUCTR)	16/03/2018	22/12/2017	A Phase 3 clinical study to Evaluate the Efficacy and Safety of ALXN1840 in adult and adolescent pat ...	A Phase 3, Randomized, Rater-Blinded, Multi-Center Study To Evaluate The Efficacy And Safety Of ALXN ...	Wilson Disease MedDRA version: 20.0;Level: LLT;Classification code 10047988;Term: Wilson's disease;S ...	Product Name: ALXN1840 INN or Proposed INN: Not applied Other descriptive name: BIS-CHOLINE TETRATHIOM ...	Alexion Pharmaceuticals, Inc	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	180	Phase 3	Serbia;United States;Portugal;Hong Kong;Taiwan;Greece;Spain;Russian Federation;Israel;Colombia;Franc ...
9	EUCTR2017-004135-36-AT (EUCTR)	27/02/2018	17/01/2018	A Phase 3 clinical study to Evaluate the Efficacy and Safety of ALXN1840 in adult and adolescent pat ...	A Phase 3, Randomized, Rater-Blinded, Multi-Center Study To Evaluate The Efficacy And Safety Of ALXN ...	Wilson Disease MedDRA version: 20.0;Level: LLT;Classification code 10047988;Term: Wilson's disease;S ...	Product Name: ALXN1840 INN or Proposed INN: Not applied Other descriptive name: BIS-CHOLINE TETRATHIOM ...	Alexion Pharmaceuticals, Inc	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	180	Phase 3	Serbia;United States;Portugal;Hong Kong;Taiwan;Greece;Spain;Russian Federation;Israel;Colombia;Franc ...
10	EUCTR2017-004135-36-HU (EUCTR)	12/02/2018	07/02/2018	A Phase 3 clinical study to Evaluate the Efficacy and Safety of WTX101 in adult patients who suffer ...	A Phase 3, Randomised, Rater-Blinded, Multi-Centre Study to Evaluate the Efficacy and Safety of WTX1 ...	Wilson Disease MedDRA version: 20.0;Level: LLT;Classification code 10047988;Term: Wilson's disease;S ...	Product Name: WTX101 Product Code: WTX101 INN or Proposed INN: Not applied Other descriptive name: BIS- ...	Wilson Therapeutics AB	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	102	Phase 3	France;United States;Czech Republic;Hungary;Poland;Spain;Austria;Israel;Germany;Italy;United Kingdom ...

First Previous1 2Next Last